Historical background of formation of ideas about arrhythmogenic cardiomyopathy (literature review)
https://doi.org/10.18705/2782-3806-2024-4-4-288-294
EDN: KQCSOB
Abstract
Over the past 40 years, the understanding of arrhythmogenic cardiomyopathy (ACM) has changed significantly. Thus, with the advent of new knowledge, different terms have been used to name this heart disease: arrhythmogenic right ventricular dysplasia (ARVD), arrhythmogenic right ventricular cardiomyopathy (ARVC), and arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/ARVD). In 1995, this heart disease was included in the World Health Organization classification of cardiomyopathies under the name ARVC. With the discovery of the left ventricular variant, the term ACM was introduced. The review presents generalized historical aspects in the development of knowledge about this pathology: from the first mention of the disease to the present.
Supporting agencies: The research was carried out with the financial support of the Ministry of Science and Higher Education of the Russian Federation (Agreement No. 075-15-2022- 301 dated 04/20/2022)
About the Authors
O. A. Kofeynikova
Almazov National Medical Research Centre, World-Class Research Centre for Personalized Medicine
Russian Federation
Russian Federation
Olga A. Kofeynikova, Junior Researcher, Pediatric Cardiologist
Research Institute of Unknown, Rare and Genetically Caused Diseases; Department of Pediatric Cardiology and Medical Rehabilitation of
Perinatology and Pediatrics
197314; Akkuratova str., 2; Saint Petersburg
D. Yu. Alekseeva
Almazov National Medical Research Centre, World-Class Research Centre for Personalized Medicine
Russian Federation
Russian Federation
Darya Yu. Alekseeva, СM, Researcher
Research Institute of Unknown, Rare and Genetically Caused Diseases
Saint Petersburg
A. G. Shilina
Almazov National Medical Research Centre, World-Class Research Centre for Personalized Medicine
Russian Federation
Russian Federation
Anna G. Shilina, Pediatric Cardiologist
Consultative and Diagnostic Department of Perinatology and Pediatrics
Saint Petersburg
N. S. Kulchitskaya
Almazov National Medical Research Centre, World-Class Research Centre for Personalized Medicine
Russian Federation
Russian Federation
Natalya S. Kulchitskaya, Pediatric Cardiologist
Consultative and Diagnostic Department of Perinatology and Pediatrics
Saint Petersburg
E. S. Vasichkina
Almazov National Medical Research Centre, World-Class Research Centre for Personalized Medicine
Russian Federation
Russian Federation
Elena S. Vasichkina, PhD, MD, Head of the Centre, Professor
Scientific Research Centre for Unknown, Rare and Genetically Caused Diseases;
Institute of Medical Education; Medical Faculty; Department of Pediatric Diseases
Saint Petersburg
References
1. Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med 2017;376:61–72. DOI: 10.1056/NEJMra1509267.
2. Marcus F, Fontaine G, Guirdaudon G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65:384–398. DOI: 10.1161/01.cir.65.2.384.
3. Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. HeartRhythm. 2019 Nov;16(11):e301–e372. DOI: 10.1016/j.hrthm.2019.05.007.
4. Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary. Heart Rhythm. 2020 Jan;17(1):e155–e205. DOI: 10.1016/j.hrthm.2019.03.014.
5. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994 Mar;71(3):215–8. DOI: 10.1136/hrt.71.3.215.
6. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. European Heart Journal. 31, 806–814. DOI: 10.1093/eurheartj/ehq025.
7. Corrado D, Perazzolo Marra M, Zorzi A, et al. Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria. Int J Cardiol. (2020) 319:106–14. DOI: 10.1016/j.ijcard.2020.06.005.
8. Marrone D, Zampieri F, Basso C, et al. History of the discovery of Arrhythmogenic Cardiomyopathy. Eur. Heart J. 2019;40:1100–1104. DOI: 10.1093/eurheartj/ehz145.
9. Lancisi GM. De Motu Cordis et Aneurysmatibus. G. M. Salvioni; Roma, Italy: 1728. Book II, Ch. VI, Par. XLVII.
10. Fontaine G, Chen HS. Arrhythmogenic right ventricular dysplasia back in force. Am J Cardiol. 2014 May 15;113(10):1735–9. DOI: 10.1016/j.amjcard.2014.03.001.
11. Marcus FI, Fontaine GH, Guiraudon G, et al. Right ventricular dysplasia: A report of 24 adult cases. Circulation. 1982;65:384–398. DOI: 10.1161/01.CIR.65.2.384.
12. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988 Jan 21;318(3):129–33. DOI: 10.1056/NEJM198801213180301.
13. Aquaro GD, De Luca A, Cappelletto C, et al. Prognostic value of magnetic resonance phenotype in patients with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2020;2753–2765.
14. Chen X, Li L, Cheng H, et al. Early left ventricular involvement detected by cardiovascular magnetic resonance feature tracking in arrhythmogenic right ventricular cardiomyopathy: the effects of left ventricular late gadolinium enhancement and right ventricular dysfunction. J Am Heart Assoc. 2019;9:e012989. DOI: 10.1161/JAHA.119.012989.
15. Corrado D, Zorzi A, Cipriani A, et al. Scarring/arrhythmogenic cardiomyopathy. Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C144–C154. DOI: 10.1093/eurheartjsupp/suad017.
16. Corrado D, Anastasakis A, Basso C, et al. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report. Int J Cardiol. 2024 Jan 15;395:131447. DOI: 10.1016/j.ijcard.2023.131447. Epub 2023 Oct 14. PMID: 37844667.
17. Arbelo E, Protonotarios A, Gimeno JR, et al. ESC Scientific Document Group, 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). European Heart Journal. Vol. 44, Issue 37, 1 October 2023, Pages 3503–3626. doi: 10.1093/eurheartj/ehad194
18. Comments on the 2023 ESC guidelines for the management of cardiomyopathies, Revista Española de Cardiología (English Edition). 2023. doi: 10.1016/j.rec.2023.11.008.
Review
For citations:
Kofeynikova O.A., Alekseeva D.Yu., Shilina A.G., Kulchitskaya N.S., Vasichkina E.S. Historical background of formation of ideas about arrhythmogenic cardiomyopathy (literature review). Russian Journal for Personalized Medicine. 2024;4(4):288-294. (In Russ.) https://doi.org/10.18705/2782-3806-2024-4-4-288-294. EDN: KQCSOB
Views:
128
Email this article 